169 related articles for article (PubMed ID: 22359292)
1. DNA methylation changes in cervical cancers.
Lu Q; Ma D; Zhao S
Methods Mol Biol; 2012; 863():155-76. PubMed ID: 22359292
[TBL] [Abstract][Full Text] [Related]
2. Specific type epigenetic changes in cervical cancers.
Zhao S
Methods Mol Biol; 2015; 1238():733-49. PubMed ID: 25421689
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic alterations in cervical carcinogenesis.
Szalmás A; Kónya J
Semin Cancer Biol; 2009 Jun; 19(3):144-52. PubMed ID: 19429477
[TBL] [Abstract][Full Text] [Related]
4. Epigenetics of cervical cancer. An overview and therapeutic perspectives.
Dueñas-González A; Lizano M; Candelaria M; Cetina L; Arce C; Cervera E
Mol Cancer; 2005 Oct; 4():38. PubMed ID: 16248899
[TBL] [Abstract][Full Text] [Related]
5. DNA hypermethylation as an epigenetic mark for oral cancer diagnosis.
Radhakrishnan R; Kabekkodu S; Satyamoorthy K
J Oral Pathol Med; 2011 Oct; 40(9):665-76. PubMed ID: 21649736
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic analysis in the search for tumor suppressor genes.
Han ZG
Epigenomics; 2010 Aug; 2(4):489-93. PubMed ID: 22121966
[No Abstract] [Full Text] [Related]
7. Hypomethylated CpG around the transcription start site enables TERT expression and HPV16 E6 regulates TERT methylation in cervical cancer cells.
Jiang J; Zhao LJ; Zhao C; Zhang G; Zhao Y; Li JR; Li XP; Wei LH
Gynecol Oncol; 2012 Mar; 124(3):534-41. PubMed ID: 22108635
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic changes in prostate cancer: implication for diagnosis and treatment.
Li LC; Carroll PR; Dahiya R
J Natl Cancer Inst; 2005 Jan; 97(2):103-15. PubMed ID: 15657340
[TBL] [Abstract][Full Text] [Related]
9. The epigenetics of oral cancer.
Shaw R
Int J Oral Maxillofac Surg; 2006 Feb; 35(2):101-8. PubMed ID: 16154320
[TBL] [Abstract][Full Text] [Related]
10. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of genetic and epigenetic alterations in cancer.
Toyota M; Suzuki H; Yamamoto E; Yamano H; Imai K; Shinomura Y
Epigenomics; 2009 Dec; 1(2):291-9. PubMed ID: 22122704
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic drivers of genetic alterations.
Toyota M; Suzuki H
Adv Genet; 2010; 70():309-23. PubMed ID: 20920753
[TBL] [Abstract][Full Text] [Related]
13. Antisense RNAs and epigenetic regulation.
Cui I; Cui H
Epigenomics; 2010 Feb; 2(1):139-50. PubMed ID: 22122750
[TBL] [Abstract][Full Text] [Related]
14. Aberrant epigenetic silencing of tumor suppressor genes is reversed by direct reprogramming.
Ron-Bigger S; Bar-Nur O; Isaac S; Bocker M; Lyko F; Eden A
Stem Cells; 2010 Aug; 28(8):1349-54. PubMed ID: 20572015
[TBL] [Abstract][Full Text] [Related]
15. Silencing of multi-copy HPV16 by viral self-methylation and chromatin occlusion: a model for epigenetic virus-host interaction.
De-Castro Arce J; Göckel-Krzikalla E; Rösl F
Hum Mol Genet; 2012 Apr; 21(8):1693-705. PubMed ID: 22210627
[TBL] [Abstract][Full Text] [Related]
16. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
17. Methylation of the long control region of HPV16 is related to the severity of cervical neoplasia.
Ding DC; Chiang MH; Lai HC; Hsiung CA; Hsieh CY; Chu TY
Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):215-20. PubMed ID: 19819061
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells.
Rincon-Orozco B; Halec G; Rosenberger S; Muschik D; Nindl I; Bachmann A; Ritter TM; Dondog B; Ly R; Bosch FX; Zawatzky R; Rösl F
Cancer Res; 2009 Nov; 69(22):8718-25. PubMed ID: 19887612
[TBL] [Abstract][Full Text] [Related]
19. Role of epigenetic alterations in cholangiocarcinoma.
Tischoff I; Wittekind C; Tannapfel A
J Hepatobiliary Pancreat Surg; 2006; 13(4):274-9. PubMed ID: 16858537
[TBL] [Abstract][Full Text] [Related]
20. Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma.
Kang S; Kim HS; Seo SS; Park SY; Sidransky D; Dong SM
Gynecol Oncol; 2007 Jun; 105(3):662-6. PubMed ID: 17360030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
